Supplementary file to: Efficacy and Safety of Picankibart Versus Placebo in Adults with Moderate-to-Severe Plaque Psoriasis: The CLEAR-1 Randomized Clinical Trial

Name: Supplementary file to: Efficacy and Safety of Picankibart Versus Placebo in Adults with Moderate-to-Severe Plaque Psoriasis: The CLEAR-1 Randomized Clinical Trial
Creator: Yunlu Gao
Published: 2025-09-03T17:59:02.001Z
Keywords: Clinical Trial

Gao, Yunlu; Qin, Lanying; Li, Yumei; Cui, Yong; Zhang, Shifa; Liu, Lunfei; Wang, Lihua; Ci, Chao; Lu, Jianyun; Chen, Rixin; Feng, Yanyan; Li, Shanshan; Cai, Chenghang; Chen, Mingxia; Han-Zhang, Han; Li, Yue; Qian, Lei; Shi, Yuling

doi:10.17632/9xd2xy8tdj.1

Supplementary file to: Efficacy and Safety of Picankibart Versus Placebo in Adults with Moderate-to-Severe Plaque Psoriasis: The CLEAR-1 Randomized Clinical Trial

Published: 3 September 2025| Version 1 | DOI: 10.17632/9xd2xy8tdj.1

Contributors:

Yunlu Gao, Lanying Qin, Yumei Li, Yong Cui, Shifa Zhang, Lunfei Liu, Lihua Wang, Chao Ci, Jianyun Lu, Rixin Chen, Yanyan Feng, Shanshan Li, Chenghang Cai, Mingxia Chen, Han Han-Zhang, Yue Li, Lei Qian,

Description

This supplementary document contains supplemental figures and tables that have been referenced in the main text.

Files

Funders

Innovent Biologics Co. Ltd., Suzhou, China

Supplementary file to: Efficacy and Safety of Picankibart Versus Placebo in Adults with Moderate-to-Severe Plaque Psoriasis: The CLEAR-1 Randomized Clinical Trial

Description

Files

Categories

Funders

Licence